Jabbour, E., Branford, S., Saglio, G., Jones, D., Cortes, J. E., & Kantarjian, H. M. (2010). Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia.

Jabbour, Elias, Susan Branford, Giuseppe Saglio, Dan Jones, Jorge E. Cortes, und Hagop M. Kantarjian. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.

Jabbour, Elias, et al. Practical Advice for Determining the Role of BCR-ABL Mutations in Guiding Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia. 2010.